This recent report puts a fly model of Huntington's Disease to use in a study exploring the potential of methylene blue as a treatment for the disease.
Sontag EM, Lotz GP, Agrawal N, Tran A, Aron R, Yang G, Necula M, Lau A, Finkbeiner S, Glabe C, Marsh JL, Muchowski PJ, Thompson LM. Methylene Blue Modulates Huntingtin Aggregation Intermediates and Is Protective in Huntington's Disease Models. J Neurosci. 2012 Aug 8;32(32):11109-11119. PubMed PMID: 22875942.
The fly model used in the study is available from the BDSC. Stock number 6923.
Additional Huntington's Disease-related stocks at BDSC can be found here.
No comments:
Post a Comment